Italfarmaco and VeriSIM Life Partner to Develop Novel HDAC-Targeting Therapeutics for Neuromuscular, Fibrotic, and Rare Diseases
Italfarmaco and VeriSIM Life Partner to Develop Novel HDAC-Targeting Therapeutics for Neuromuscular, Fibrotic, and Rare Diseases Italfarmaco S.p.A., a global pharmaceutical company with established expertise in histone deacetylase biology and therapeutic development, and VeriSIM Life, an AI-enabled drug discovery and…
AstraZeneca Opens New Global R&D Center in Cambridge’s Kendall Square
AstraZeneca opens new global strategic R&D center in Kendall Square, Cambridge, Massachusetts AstraZeneca announced the opening of its newest global strategic research and development (R&D) center, in Kendall Square, Cambridge, Massachusetts. The new state-of-the-art facility builds on the Company’s existing…
Mitsui Chemicals Launches InnoCell™ P-Type High-Oxygen Culture Plates for Faster Organoid Drug Discovery
Mitsui Chemicals Launches InnoCell™ P-Type High Oxygen-Permeable Culture Plates to Accelerate Organoid-Based Drug Discovery Mitsui Chemicals, Inc. has launched InnoCell™ P-Type, a new adherent cell culture plate in its InnoCell™ series of cell culture ware, as of October 1, 2026.…
NeuWire Medical Receives FDA IDE Approval for STROKE-REWIRE Pivotal Study in Chronic Ischemic Stroke
NeuWire Medical Announces FDA IDE Approval for STROKE-REWIRE Pivotal Study in Chronic Ischemic Stroke NeuWire Medical announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application for STROKE-REWIRE, a pivotal study evaluating the…
Italfarmaco and JCR Pharmaceuticals Sign Exclusive License Deal for Hunter Syndrome Therapy
Italfarmaco and JCR Pharmaceuticals Enter into Exclusive License Agreement for the Development and Potential Commercialization of Novel Investigational Therapy for Hunter Syndrome in the United States, Europe, and Latin America Italfarmaco S.p.A. and JCR Pharmaceuticals Co., Ltd. announced an exclusive…
Summit Therapeutics Partners with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab with Datroway
Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway Summit Therapeutics Inc. announced a clinical trial collaboration agreement with Daiichi Sankyo and AstraZeneca to evaluate ivonescimab, a novel, potential…
SOLVE FSHD Advances Development of SFH-4090, a Novel DUX4 Inhibitor for FSHD
SOLVE FSHD Accelerates Development of SFH-4090, a Novel DUX4 Inhibitor for FSHD SOLVE FSHD announced new nonclinical data supporting SFH-4090 for the treatment of facioscapulohumeral muscular dystrophy (FSHD). The data were presented at the 31st Annual Congress of the World…
Longevica Builds Advisory Board to Advance Human Health and Longevity Pipeline
Beyond Cellular Models: Longevica Capitalizes on World’s Largest In Vivo Longevity Study to Form Star-Studded Advisory Board and Unlock Human Health-and-Lifespan Pipeline Longevica Therapeutics, a biotechnology company bridging the translation gap between empirical geroscience and human therapeutics, announced the formation…
TriLink BioTechnologies Secures New China Patent for CleanCap Technology, Strengthening Global IP Protection
TriLink BioTechnologies® Secures Additional China Patent for CleanCap® Technology, Adding Broad Composition-of-Matter Protection to Reinforce Its Global IP TriLink BioTechnologies, LLC a Maravai LifeSciences company and global provider of life science reagents and services, announced it has been granted a…
Vividion Publishes VVD-214 Clinical Data in Nature Medicine, Highlighting Its Potential for Colorectal Cancer
Vividion Announces Publication of Clinical Data for VVD-214 in Nature Medicine, Highlighting Potential in Colorectal Cancer Vividion Therapeutics, Inc. a clinical-stage biopharmaceutical company and a wholly owned and independently operated subsidiary of Bayer AG, today announced the publication of the…
Estée Lauder and Breast Cancer Research Foundation Launch Major Global Study on Breast Cancer in Younger Women
The Estée Lauder Companies and the Breast Cancer Research Foundation Launch Largest Global Research Initiative on Breast Cancer in Younger Women The Estée Lauder Companies announced a new five-year commitment to the Breast Cancer Research Foundation to establish the Global…
Enveda Raises $311 Million to Advance AI-Powered Drug Discovery
Enveda Raises $311 Million From Leading AI and Biotech Investors to Bring Pharma Into the 21st Century Enveda, a clinical-stage biotechnology company that uses AI to discover medicines from life’s chemistry, announced the close of a $311 million Series E…